KL In the News | FierceBiotech.com – Rare disease advocates stage ‘funeral’ at FDA, demand 4 actions of agency and Congress

The demonstration comes as controversy around the FDA’s rare disease decisions continues to escalate following uniQure’s heated back-and-forth and several unexpected rejections.